Bunkerhill Abdominal Aortic Quantification (AAQ) vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill Abdominal Aortic Quantification (AAQ)

by Bunkerhill Health

ElucidVivo A.3

by Elucid

AI Verdict

Bunkerhill Abdominal Aortic Quantification (AAQ) focuses on the automated quantification of abdominal aortic diameter for aneurysm detection and follow-up. ElucidVivo A.3, conversely, specializes in the quantitative analysis of arterial plaque composition and stability to aid in atherosclerosis patient stratification. While both are FDA-cleared AI tools for cardiovascular imaging, they address distinct aspects of vascular health, making them complementary rather than directly competitive.

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if…

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if your primary goal is the automated detection and ongoing surveillance of abdominal aortic aneurysms. This tool excels at quantifying aortic diameter on both contrast and non-contrast CT scans, enabling opportunistic screening and streamlining follow-up workflows for aneurysm management. It's ideal for integrating guideline-based surveillance and coordinating actions within clinical workflows based on aortic measurements.

View Bunkerhill Abdominal Aortic Quantification (AAQ) →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if you need detailed, quantitative analysis of arterial plaque composition and stability from CT angiography to stratify atherosclerosis patients. This system provides objective measurements of lipid-rich necrotic core, matrix, and calcifications, offering critical insights into plaque characteristics validated against histology. It's best suited for optimizing treatment decisions by understanding lesion-level plaque composition and deriving fractional flow reserve (FFRct).

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill Abdominal Aortic Quantification (AAQ)	ElucidVivo A.3
Deployment	Cloud-based (Carebricks platform)	Cloud and on-premise secure deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A emphasizes 'seamless integration with Electronic Health Records (EHRs)' and 'automation of appropriate next steps and actions within clinical workflows' through its Carebricks platform, suggesting a highly integrated and streamlined user experience. Its cloud-based deployment also typically offers easier setup and maintenance compared to potentially on-premise solutions.

Clinical Value

ElucidVivo A.3

While both tools offer significant clinical value, Tool B provides a deeper, more granular analysis of arterial plaque composition and stability, validated against histology, and derives fractional flow reserve (FFRct). This detailed quantitative analysis is crucial for precise atherosclerosis patient stratification and treatment optimization.

Pricing & Value

Tie

Both tools state 'contact for pricing' and do not provide any public details on their pricing models or specific value propositions. Without transparent pricing or comparative ROI data, it is impossible to determine a winner in this dimension.

Enterprise Readiness

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A explicitly states HIPAA compliance, FDA clearance, and cloud-based deployment utilizing AWS, along with seamless EHR integration, indicating robust enterprise readiness. While Tool B is FDA-cleared and implies HIPAA compliance, its deployment details are less specific, and BAA is not explicitly stated.

Innovation

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A positions itself as 'the generative AI platform for clinical reasoning and action' and mentions 'AI-powered reasoning across structured and unstructured patient data,' suggesting a broader and more advanced application of AI beyond image quantification. While Tool B's detailed plaque analysis is innovative, Tool A's focus on generative AI and clinical reasoning points to a more forward-looking technological approach.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information from web searches offer specific details regarding the support services, documentation, or training resources for either Tool A or Tool B. Therefore, it is not possible to distinguish between them in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill Abdominal Aortic Quantification (AAQ)	ElucidVivo A.3
Primary Clinical Focus	Abdominal Aortic Aneurysm detection and surveillance	Arterial plaque composition and stability analysis for atherosclerosis patient stratification
Analyzed Imaging Modality	Contrast and non-contrast CT scans	CT angiography
Specific Quantification/Analysis	Automated abdominal aortic diameter quantification, detection of interval growth in aortic measurements	Quantitative analysis of Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications; derivation of fractional flow reserve (FFRct)
Company	BunkerHill Health	Elucid Bioimaging
Key Integration	Carebricks platform, Electronic Health Records (EHRs)	PACS/EMR (implied)
Advanced Visualization Features	Not specified	3D visualization of highlighted vessels, rotatable curved MPR vessel views and cross-sections
Validation Method	Not specified	Validated on ground-truth histology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill Abdominal Aortic Quantification (AAQ) and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical difference in focus between Bunkerhill Abdominal Aortic Quantification (AAQ) and ElucidVivo A.3?

Bunkerhill AAQ is designed to automate abdominal aortic diameter quantification on CT scans for early aneurysm detection and streamlined follow-up within the Carebricks platform. ElucidVivo A.3, conversely, focuses on providing quantitative analysis of arterial plaque composition and stability from CT angiography to assist physicians in atherosclerosis patient stratification and optimize treatment decisions.

What specific quantitative measurements do these tools provide?

Bunkerhill AAQ provides automated abdominal aortic diameter quantification and detects interval growth in aortic measurements beyond configured thresholds. ElucidVivo A.3 objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, and derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.

What types of imaging studies are compatible with each AI tool?

Bunkerhill AAQ is cleared to automate abdominal aortic diameter quantification on both contrast and non-contrast CT scans. ElucidVivo A.3 performs quantitative analysis of arterial plaque composition and stability from CT angiography.

How do these tools integrate into existing clinical workflows and support automated actions?

Bunkerhill AAQ integrates with the Carebricks platform for automated follow-up workflows, guideline-based surveillance, and coordination, and can automate appropriate next steps and actions within clinical workflows, including EHR integration. ElucidVivo A.3 is a software application that integrates with PACS/EMR, but specific automated follow-up workflows are not explicitly detailed.

What evidence of validation is available for each tool's accuracy and clinical utility?

Both Bunkerhill AAQ and ElucidVivo A.3 are FDA-cleared. ElucidVivo A.3's plaque analysis is specifically validated against ground-truth histology, which is considered the gold standard for plaque characterization.